Differential metabolite production underlies disruption of the cystic fibrosis airway microbiota by pathogens
mSystems · 06.11.2026
DOI: 10.1128/msystems.01157-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSystems, online erschienen am 06.11.2026. Verfasst von Sydney M Morabbi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA. Die Arbeit nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of General Medical Sciences, National Center for Complementary and Integrative Health.
Abstract (Originalsprache)
Cystic fibrosis (CF) results in accumulation of mucus in the airways that promotes pathogen colonization, leading to respiratory exacerbations, lung failure, and death. The CF airway harbors a complex microbiota, including pathogens and oropharyngeal bacteria. Here, we reanalyzed 5,260 16S rRNA gene microbiota data sets to infer associations between members of the CF microbiota. We determined that pathogens are more likely to proliferate and dominate when present, while oropharyngeal bacteria are generally present at lower abundances. We found that higher diversity and increasing numbers of pairwise associations between bacteria were positively correlated with lung function. In contrast, dominance of the microbiota by pathogens was associated with loss of lung function. We determined that pathogens are largely negatively associated with each other and oropharyngeal bacteria, suggesting they are antagonistic toward other bacteria. As a first test of this hypothesis, we cultured 1,597 isolates from 96 people with CF and performed 12,542 coculture assays against eight representative pathogens and oropharyngeal bacteria, finding 23% of interactions resulted in inhibition. Among our isolates, Pseudomonas were the most inhibitory, but we observed variable activity between different isolates. We further found Pseudomonas aeruginosa isolates, even those from the same donor and time point, exhibited significant differences in their metabolome and bioactivity profiles that correlated with acquisition of mutations. Together, our results suggest that pathogens may disrupt the CF microbiota and proliferate in part through bioactive metabolite production. Furthermore, these data highlight that characterizing multiple isolates is necessary to capture the full landscape of chemically mediated interactions within microbiomes. IMPORTANCE The cystic fibrosis (CF) airway harbors a complex microbiota, including oropharyngeal bacteria and opportunistic pathogens that establish chronic infections. We found that microbiota diversity is correlated with health and that a pathogen-dominated microbiota is associated with low lung function. We then inferred potential microbial interactions by determining abundance associations between CF genera, which suggested that pathogens antagonize other bacteria. To test this prediction, we cultured bacteria from people with CF and performed thousands of coculture assays, finding that approximately one-quarter of interactions resulted in growth inhibition. Pseudomonas broadly inhibited other members of the CF airway microbiota. However, we observed marked variability in bioactivity and metabolite profiles of Pseudomonas aeruginosa isolates, even from the same donor at the same time. Our results suggest that pathogens disrupt the CF microbiota, possibly through bioactive metabolite production, and that characterizing multiple isolates is necessary to capture the complete picture of interactions in these communities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Molecular Genetics, Oklahoma State University, Stillwater, Oklahoma, USA.
- Department of Pharmaceutical Sciences, Oregon State University, Corvallis, Oregon, USA.
ORCID-Profile: Erika I Lutter, Benjamin Philmus, Reed M Stubbendieck
Förderung
- National Institute of General Medical Sciences
- National Center for Complementary and Integrative Health
Zitieren
APA
Morabbi, S. M., Bhowmik, N., Sutherland, S., Wylie, E. A., Decker, R. S., Al Daerwish, A., Pérez Pérez, M., Pascual, E., Lutter, E. I., Philmus, B., & Stubbendieck, R. M. (2026). Differential metabolite production underlies disruption of the cystic fibrosis airway microbiota by pathogens. mSystems. https://doi.org/10.1128/msystems.01157-26
Vancouver
Morabbi SM, Bhowmik N, Sutherland S, Wylie EA, Decker RS, Al Daerwish A, et al. Differential metabolite production underlies disruption of the cystic fibrosis airway microbiota by pathogens. mSystems. 2026. doi:10.1128/msystems.01157-26
BibTeX
@article{Morabbi2026,
author = {Morabbi, Sydney M and Bhowmik, Niladri and Sutherland, Shaz and Wylie, Evelyn A and Decker, Reagan S and Al Daerwish, Akram and Pérez Pérez, Mercedes and Pascual, Elizabeth and Lutter, Erika I and Philmus, Benjamin and Stubbendieck, Reed M},
title = {Differential metabolite production underlies disruption of the cystic fibrosis airway microbiota by pathogens},
journal = {mSystems},
year = {2026},
doi = {10.1128/msystems.01157-26}
}
EUVIMED